Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies

Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies, 2020-2030.”

The report features an extensive study of the current market landscape and future potential of these therapeutics and affiliated technologies, over the next decade. This study focuses specifically on small molecule STING modulators. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:

A detailed assessment of the current market landscape of therapeutics targeting STING Pathway.

A detailed assessment of the current market landscape of various technology platforms that are being actively used for the development of STING modulators.

Detailed profiles of developers of therapeutics targeting STING pathway (shortlisted on the basis of phase of development of pipeline products).

An in-depth analysis of more than 280 grants that have been awarded to research institutes engaged in STING pathway targeting therapeutics-related projects.

An analysis of the initiatives of big pharma players engaged in this domain.

An analysis of the start-ups / small players (established in the last ten years, less than 50 employees) engaged in the development of STING pathway targeting therapeutics.

A detailed publication analysis of more than 300 peer-reviewed, scientific articles that have been published during the period 2019 – Q1 2020.

An analysis of the partnerships that have been established in this domain, in the recent past.

An analysis of the investments made in this domain.

  • A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Types of Payment

Upfront Payments

Milestone Payments

Type of STING Modulator

Agonist

Antagonist

Key Therapeutic Area(s)

Oncological Disorders

Inflammatory Disorders

Infectious Diseases

Others

Route of Administration

Intratumoral

Intravenous

Oral

Subcutaneous

Others

Type of Molecule

Non-nucleotide

Cyclic Dinucleotide

Live Biotherapeutics

Oncolytic Peptides

Synthetic Peptides

Others

Key Geographical Regions

North America

Europe

Asia-Pacific

Key companies covered in the report

  • Aduro Biotech
  • Bristol Myers Squibb
  • Eisai
  • GlaxoSmithKline
  • ImmuneSensor Therapeutics
  • Merck
  • Noxopharm
  • Spring Bank Pharmaceuticals

Synlogic

For more information please click on the following link:

https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html

Other Recent Offerings

 

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook – https://www.facebook.com/RootsAnalysis

LinkedIn – https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter – https://twitter.com/RootsAnalysis

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe